课题基金 / 基金详情

项目摘要

项目成果

Cyrus Vaziri的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请方提供):本提案的广泛长期目标是阐明苯并法芘(B[a]P)诱导的S期检查点的分子基础。B[a]P是一种丰富且普遍存在的环境致癌物,其在细胞内代谢产生苯并[a]芘二氢二醇环氧化物(BPDE)。BPDE诱导的DMA损伤触发了协调基因组复制和修复的S期检查点信号通路。然而,检查点信号调节DNA复制的分子机制还不完全清楚。受损DNA的不准确修复和复制可导致基因组不稳定,这是癌细胞的标志。在B[a]P暴露后,BPDE诱导的S期检查点可能有助于维持基因组稳定性并预防癌症。本申请将研究S期检查点被DNA损伤激活的机制,以及能够从检查点恢复的跨损伤合成(TLS)介导的机制。我们的研究表明,Cdc45(DNA复制因子)和DNA聚合酶Pol kappa(Pol?)分别参与S期检查点的激活和恢复。我们还表明,波尔?由E3泛素连接酶Rad18调节。该提议的具体目的是:(1)检验Cdc45是BPDE诱导的S期检查点的靶标的假设。(2)阐明Rad18在从BPDE诱导的S期检查点恢复中的作用。(3)为了阐明波尔的作用,相互作用的DNA聚合酶Rev1在检查点恢复。目的1和2将鉴定并突变Cdc45泛素化位点(目的1)和Rad18磷酸化位点(目的2)。然后我们将研究检查点信号对泛素化和磷酸化抗性突变体的调控。这些实验将测试Cdc45遍在蛋白化和Rad18磷酸化与S期检查点相关的重要性。在目标3中,我们将确定消融Rev1(与Pol?在Pol?调控这些研究将确定如何之间的相互作用波尔? 和Rev1调节S期检查点。总之,这些实验将为DNA复制机制与DNA修复蛋白协调以响应B[a]P(和可能的其他基因毒素)以维持基因组稳定性的机制提供新的范例。我们的研究结果可能有助于识别环境B[a] P诱导疾病的高风险个体。此外,我们的研究可以帮助确定癌症治疗的新药物靶点:与B[a]P类似,许多化疗药物具有遗传毒性并激活检查点途径。我们已经表明,波尔?或Rad18缺乏使细胞对B[a] P诱导的死亡敏感。潜在地,靶向Rad18、Pol?或其它TLS酶可使癌细胞对化疗剂的杀伤敏感。
英文摘要
DESCRIPTION (provided by applicant): The broad long-term objective of this proposal is to elucidate the molecular basis of the Benzofalpyrene (B[a]P)-induced S-phase checkpoint. B[a]P is an abundant and ubiquitous environmental carcinogen that is metabolized intracellularly to generate Benzo[a]pyrene Di-hydrodiol-Epoxide (BPDE). BPDE-induced DMA damage triggers S-phase checkpoint signaling pathways that coordinate replication and repair of the genome. However, the molecular mechanism(s) by which checkpoint signaling regulates DNA replication are incompletely understood. Inaccurate repair and replication of damaged DNA can result in genomic instability, a hallmark of cancer cells. The BPDE-induced S-phase checkpoint is likely to help maintain genomic stability and prevent cancer after B[a]P exposure. This application will investigate the mechanisms by which S-phase checkpoints are activated by DNA damage, and the Trans-Lesion Synthesis (TLS)-mediated mechanisms that enable recovery from the checkpoint. Our studies indicate that Cdc45 (a DNA replication factor) and DNA polymerase Pol kappa (Pol?) are involved in S-phase checkpoint activation and recovery respectively. We have also shown that Pol? is regulated by the E3 ubiquitin ligase Rad18. The Specific Aims of this proposal are: (1) To test the hypothesis that Cdc45 is a target of the BPDE-induced S- phase checkpoint. (2) To elucidate the role of Rad18 in recovery from the BPDE-induced S-phase checkpoint. (3) To elucidate the role of the Pol?-interacting DNA polymerase Rev1 in checkpoint recovery. Aims 1 and 2 will identify and mutate sites of Cdc45 ubiquitination (Aim 1) and Rad18 phosphorylation (Aim 2). Then we will study the regulation of ubiquitination and phosphorylation-resistant mutants by checkpoint signaling. These experiments will test the significance of Cdc45 ubiquitination and Rad18 phosphorylation in relation to the S-phase checkpoint. In Aim 3 we will determine the effect of ablating Rev1 (which interacts physically and genetically with Pol?) on Pol? regulation. These studies will determine how interactions between Pol? and Rev1 regulate the S-phase checkpoint. Together, these experiments will provide a novel paradigm for the mechanisms by which the DNA replication machinery is coordinated with DNA repair proteins in response to B[a]P (and .possibly other genotoxins) to maintain genomic stability. Results of our studies might help identify individuals that are at high-risk for environmental B[a]P-induced disease. Moreover, our studies could help identify novel drug targets for cancer therapy: Similar to B[a]P, many chemotherapies are genotoxic and activate checkpoint pathways. We have shown that Pol? or Rad18- deficiency sensitizes cells to B[a]P-induced death. Potentially, small molecules that target Rad18, Pol?, or other TLS enzymes could sensitize cancer cells to killing by chemotherapeutic agents.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Defining Mechanisms of Pathological Trans-Lesion Synthesis During Carcinogenesis
Defining Mechanisms of Pathological Trans-Lesion Synthesis During Carcinogenesis
Novel Rad18 functions in Histone Modification and Regulation of Gene Expression
Targeting the TLS DNA Damage Tolerance Pathway for Cancer Therapy
海外基金